Relying on Herd immunity to fight Coronavirus is 'too large a risk', timely interventions can mitigate the spread: CSIR

Three different approaches are being taken for vaccine - One is an immune-boosting, another is a monoclonal antibody and the third is a convalescent plasma therapy.

Press Trust of India June 03, 2020 17:07:16 IST
Relying on Herd immunity to fight Coronavirus is 'too large a risk', timely interventions can mitigate the spread: CSIR

Banking on developing herd immunity to fight coronavirus is “too large a risk" for any nation and only timely interventions can mitigate the spread of COVID-19 , Director General of the Council of Scientific and Industrial Research (CSIR) Shekhar Mande said.

Herd immunity is achieved when the majority of the population becomes immune to an infectious disease, either because they have become infected and recovered, or through vaccination.

When that happens, the disease is less likely to spread to people who aren't immune, because there just aren't enough carriers.

Responding to a question on whether it is viable for India to achieve herd immunity, Mande said, "It is too large a risk for any nation."

Relying on Herd immunity to fight <span class=coronavirus is too large a risk timely interventions can mitigate the spread CSIR" width="1280" height="720" />

Herd immunity is achieved when the majority of the population becomes immune to an infectious disease, either because they have become infected and recovered, or through vaccination.

"Herd immunity typically works when 60-70 percent population of a country has been affected and it’s too large a risk to take for any nation. What one would do is to take intervention before so that the infection does not spread," he told PTI in an interview.

Mande said several theoretical modelling that people have conducted across the world and also in India seems to suggest that there could be few waves of COVID-19 and people need to be prepared for them.

"The number of cases will go down and people need to be prepared as there can be a second wave of COVID-19 ," he said.

On US President Donald Trump terminating the country's relationship with the World Health Organization (WHO) as he blamed it and China for the deaths and destruction caused by the COVID-19 pandemic across the globe, Mande said it is "not a good sign".

"WHO is a valuable body which has played an important role. It has been involved in smallpox elimination, poliovirus elimination and it has worked very well with countries. The termination of ties is not a good sign," he said.

Mande further said that the CSIR has adopted a five-pronged approach in the fight against COVID-19 focusing on, “surveillance, diagnostic, intervention through development of new therapies, hospital assistive devices and supply chain model."

On the vaccine development front, he said three different approaches are being adopted.

"One is an immune-boosting vaccine that improves the host’s immunity — that is under trial in three different locations in the country and the results are expected in the next 15 days."

"Another one is a monoclonal antibody that CSIR has funded a collaborative programme between NCCS (National Centre For Cell Science) Pune, IIT Indore and Bharat Biotech. The third one is convalescent plasma therapy whose trials are going on in Kolkata," he said.

He further said that Indian companies are "very deeply involved" in the process of vaccine development.

India registered its highest single-day spike of COVID-19 cases on Sunday with 8,380 new infections reported in the last 24 hours, taking the country's tally to 1,82,143, while the death toll rose to 5,164, according to the Union Health Ministry.

India is the ninth worst-hit nation by the COVID-19 pandemic.

Also Read: With migrants heading home, some experts call for herd immunity to combat coronavirus crisis but others warn it is no panacea

Updated Date:

also read

Visa of foreigners stranded in India due to COVID-19 pandemic extended till 31 August, says MHA
India

Visa of foreigners stranded in India due to COVID-19 pandemic extended till 31 August, says MHA

The government said that these foreign nationals will not be required to submit an application to the concerned foreigners regional registration officer for the extension of their visas

COVID-19 updates: Maharashtra, Uttar Pradesh, Tamil Nadu to ease restrictions from today; India logs 1.14 lakh cases
India

COVID-19 updates: Maharashtra, Uttar Pradesh, Tamil Nadu to ease restrictions from today; India logs 1.14 lakh cases

Meanwhile, the Telangana cabinet will meet on 8 June to take a call on the extension of lockdown to contain the spread of COVID-19, among other issues, an official release said on Sunday

Centre planning new COVID-19 vaccine strategy; mulls single shot of Covishield, mixing doses
India

Centre planning new COVID-19 vaccine strategy; mulls single shot of Covishield, mixing doses

This gains significance coming in the backdrop of India, which is battling the second wave of the COVID-19 pandemic, facing a severe vaccine shortage